1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN
Momentum Trap
Download real time
167.66 -3.36 (-1.96%)
62.84% Gain from 52W Low
280.5K
XNAS Volume

XNAS 01 Dec, 2025 1:00 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Repligen Corp is on 03 Dec 2025 for the purpose of 8(th) Annual Evercore Healthcare Conference See details

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp has a share price target of US$ 188, revenue growth forecast of 15.5%, and profit growth estimate of 287.3% for FY25, based on top 21 analyst calls.

Forecaster Screeners